Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt-Jakob disease

Neuropathology

Volumn 20, Issue 2, 2000, Pages 124-133

  Tanaka, Shinichiro ^a,b   Saito, Masaya ^a   Morimatsu, Mitsunori ^b   Ohama, Eisaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Creutzfeldt Jakob disease; Immunohistochemistry; Prion protein

Indexed keywords

FORMIC ACID; PRION PROTEIN; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN SPONGIOSIS; CELL INCLUSION; CEREBELLUM; CREUTZFELDT JAKOB DISEASE; DENTATE NUCLEUS; DISEASE DURATION; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL DEGENERATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PURKINJE CELL; SUBICULUM;

AGED; BRAIN; CEREBRAL CORTEX; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PRPSC PROTEINS;

EID: 0034108894     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00285.x     Document Type: Article

References (24)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144.
2. Kitmoto T, Shin RW, Doh-ura K et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140: 1285-94.
3. MacDonald ST, Sutherland K, Ironside JW. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies. Neurodegeneration 1996; 5: 87-94.
4. Kitmoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57: 230-236.
5. Bell JE, Gentleman SM, Ironside JW et al. Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 23: 26-35.
6. Budka H, Aguzzi A, Brown P et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 459-466.
7. Hainfellner JA, Liberski PP, Guiroy DC et al. Pathology and immunocytochemistry of a kuru brain. Brain Pathol 1997; 7: 547-553.
8. McLean CA, Ironside JW, Alpers MP et al. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 1998; 8: 429-437.
9. Bell JE, Ironside JW. Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993; 49: 738-777.
10. Masullo C, Macchi G. Resistance of the hippocampus in Creutzfeldt-Jakob disease. Clin Neuropathol 1997; 16: 37-44.
11. Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996; 380: 345-347.
12. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol 1998; 8: 449-457.
13. Muhleisen H, Gehrmann J, Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1995; 21: 505-517.
14. Eitzen UV, Egensperger R, Kosel S et al. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1998; 57: 246-256.
15. Sasaki A, Hirato J, Nakazato Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol 1993; 86: 337-344.
16. Hoque MZ, Kitmoto T, Furukawa H, Muramoto T, Tateishi J. Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: a clinicopathological, immunohistochemical and transmission study. Acta Neuropathol (Berl) 1996; 92 : 441-446.
17. Kretzschmar HA, Kitmoto T, Doerr-Schott J, Mehraein P, Tateishi J. Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol 1991; 82: 536-540.
18. Parent A. Cerebellum. In: Parent A (ed.) Carpenter's Human Neuroanatomy, 9th edn. Baltimore: Williams & Wilkins, 1996; 583-632.
19. Kitmoto T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol 1992; 141: 271-277.
20. Ironside JW, McCardle L, Hayward PA, Bell JE. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol Appl Neurobiol 1993; 19: 134-140.
21. Lowe J, McDermott H, Kenward N et al. Ubiquitin conjugate immunoreactivity in the brains of scrapie infected mice. J Pathol 1990; 162: 61-66.
22. Tanaka S, Ota M, Ohama E. A case of sporadic Creutzfeldt-Jakob disease with both plaque and synaptic type deposition of prion protein. Neuropathology 2000; 1: 49-55
23. Kitmoto T, Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci 1994; 343: 391-398.
24. Parchi P, Castellani R, Capellari S et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39: 767-778.